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This study was investigated the role that endothelial function and systemic vascular resistance (SVR) play in determining cardiac
function reserve during exercise by a new ambulatory radionuclide monitoring system (VEST) in patients with heart disease. The
study population consisted of 32 patients. The patients had cardiopulmonary stress testing using the treadmill Ramp protocol and
the VEST. The anaerobic threshold (AT) was autodetermined using the V-slope method. The SVR was calculated by determining
the mean blood pressure/cardiac output. Flow-mediated vasodilation (FMD) was measured in the brachial artery to evaluate
endotheilial function. FMD and the percent change f’rom rest to AT in SVR correlated with those from rest to AT in ejection
fraction and peak ejection ratio by VEST, respectively. Our ﬁndings suggest that FMD in the brachial artery and the SVR
determined by VEST in patients with heart disease can possibly reﬂect cardiac function reserve during aerobic exercise.
Copyright © 2009 Bonpei Takase et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Lipid abnormalities, hypertension, diabetes, smoking, and
obesity are the traditional atherosclerotic risk factors. These
risk factors cause endothelial dysfunction, inﬂammation,
and altered biological pathways [1–3] which are well-
recognized ﬁnal common pathways that lead to the devel-
opment of systemic artery atherosclerosis. These risk factors
are also associated with impaired systemic circulation, which
can also cause peripheral vascular remodeling. Peripheral
vascularremodelingsigniﬁcantlyinﬂuencessystemicperiph-
eral vascular resistance (SVR). SVR is thought to be one of
the major determinants of cardiac function during exercise
[1]. Thus, in patients with heart disease, peripheral vascular
remodeling plays a key role in the pathophysiology of
impaired exercise tolerance [4].
Flow-mediatedvasodilation(FMD)inthebrachialartery
is one of the most widely used noninvasive diagnostic
modalities [4, 5] for cardiovascular morbidity and mortality.
However, though there are many studies dealing with
endothelial function and SVR at rest, there is scant infor-
mation about the relationship between peripheral vascular
endothelial function and SVR during exercise. As well, the
relationship between peripheral endothelial function and
cardiac function reserve in response to exercise has not been
fully investigated in patients with heart disease. This lack
of information is related to the methodological diﬃculties
that preclude precise evaluation of dynamic SVR and cardiac
function during exercise [6].
However, recent advances in technology have enabled
us to measure dynamic SVR and cardiac function during
exercise at the same time. Recently, a new type of ambulatory
radionuclidemonitoring(VEST)systemhasbeendeveloped,
which can be connected to computerized ambulatory-
electrocardiogram monitoring using an IC card [7]. This
VEST system is a useful and reliable piece of equipment for2 Cardiology Research and Practice
monitoring both SVR and left ventricular function during
exercise [8, 9].
The purposes of the present study were (1) to investigate
the role that peripheral endothelial function and dynamic
changes in SVR during exercise have on left ventricular per-
formance during exercise and (2) to clarify the relationship
between peripheral endothelial function and SVR during
exercise in patients with heart disease by using the new VEST
system combined with cardiopulmonary function testing.
2. Methods
2.1. Study Population. The study population consisted of
32 men (63 ± 14 years old); 25 had coronary artery
disease (including 14 with prior myocardial infarction), 3
had dilated cardiomyopathy, and 4 were diagnosed with
hypertensive heart disease. Patients were excluded if they had
acute myocardial infarction or decompensated heart failure
within the last three months or severe valvular heart disease.
All cardiac medications were discontinued for at least ﬁve
half-lives before the study. All subjects were aware of the
investigative nature of the study and gave their informed
consent. The research protocol was approved by the Ethics
Committee of our institute that follows the Declaration of
Helsinki.
2.2. Equilibrium Radionuclide Ventriculography. All patients
had ECG-gated blood-pool scintigraphy. After an injection
of 740MBq (20mCi) of 99mTc-labeled human serum
albumin into an antecubital vein, equilibrium radionuclide
ventriculography was done at rest in the 45◦ left anterior
oblique projection. The images were obtained using a
gamma camera (GE Yokokawa, Hachiouji, Tokyo, Japan).
The imaging data were taken in a 64 × 64 matrix with a 2.0
zoom, and were acquired for an average of 300 counts per
pixel in the cardiac region of interest, with 24 frames per
cardiac cycle using a computer system. The left ventricular
ejection fraction was computed from the global time-activity
curve using the single semiautomated method.
2.3. VEST System. To measure the serial changes in left
ventricular function during cardiopulmonary stress testing,
we used the newly developed VEST system (Capintec Inc.,
Ramsey,N.J.).Thissystemconsistsoftworadiationdetectors
and an ambulatory electrocardiographic recording system.
The method employed when using this technique has been
previously described [7]. Brieﬂy, at the end of equilibrium
radionuclide ventriculography, all patients wore the VEST
garment and were positioned upright in front of the gamma
camera. Then, one-radionuclide detector was positioned
over the left ventricle while the other was placed over the
right lung ﬁeld attached to the VEST garment. The position
ofthedetectorwasconﬁrmedbyacquiringa30-secondstatic
image with the gamma camera.
After completion of cardiopulmonary stress testing, the
patients were placed in front of the gamma camera and
another 30-second static image was done to conﬁrm that
the VEST detector had not moved during the recording
interval. Left ventricular function and the electrocardiogram
were subsequently analyzed in a blind manner using the data
recorded by the instrument.
2.4. Cardiopulmonary Stress Testing. After radionuclide ven-
triculography in the supine position, the patients assumed
the upright position for symptom-limited cardiopulmonary
stress testing using a Ramp treadmill protocol (Case 12,
Marquette Electronics, Inc., Milwaukee, WI). Left ventric-
ular function was assessed using the VEST system. Using
a respiromonitor RM-300 and a gas analyzer MG-360
(AE280S, MINATO Ikagaku Inc., Osaka, Japan), breathing
patterns were analyzed and oxygen uptake (VO2), carbon
dioxide release, and ventilation were measured. Calibration
of volumes and gases were carefully done prior to each test.
The 12-lead electrocardiogram was serially monitored,
and the blood pressure was measured using the Korotkoﬀ
method every 60 seconds. The mean blood pressure was
obtained using the following formula: mean blood pres-
sure = diastolic blood pressure + (systolic blood pres-
sure − diastolic blood pressure)/3. The double product was
obtained by multiplying the systolic blood pressure by the
heart rate. Before cardiopulmonary stress testing, baseline
measurements were taken while the subjects stood for 5
minutes. Then, the patients underwent cardiopulmonary
stress testing wearing the VEST system. After peak exercise,
the recording was continued until the heart rate returned
to the baseline rate. The end points for terminating exercise
testing included: typical angina, dyspnea, extreme fatigue, or
exercise-induced ST-segment depression >2mm.
The anaerobic threshold (AT) was autodetermined using
the V-slope method and a personal computer (NEC PC-
9801) [10]. An analysis using the V-slope method was done
using the gas exchange criteria at the point of nonlinear
increase in the ventilatory equivalent for oxygen. This has
been previously associated with elevations in simultaneously
obtained arterial lactate samples without a simultaneous
increase in the ventilatory carbon dioxide equivalent [11].
Heart rate, blood pressure, workload, VO2 at rest, AT, and
peak exercise were recorded, and the measured VO2 was
divided by the body weight.
2.5. Ultrasound FMD Measurements in the Brachial Artery.
Allultrasoundstudiesweredoneinatemperature-controlled
room (25◦C)withthesubjectinafasting,resting,andsupine
state at approximately 08:00. Heavy meals, including a high-
fat diet and caﬀeine-containing beverages, were prohibited
from the night before the study. Blood pressure and heart
rate were recorded from the left arm every 3 minutes with
an automatic sphygmomanometer (Nihon Korin, BP-203,
Tokyo, Japan) during the ultrasound procedure. A 7.5MHz
high-resolution ultrasound (Hewlett-Packard, SONOS 2000,
Andover, MA, USA) was used to measure brachial artery
diameter.
FMD was then measured by a previously validated
technique [12]. Brachial artery diameter and ﬂow velocity
were imaged using a 7.5MHz high-resolution ultrasound
(Hewlett-Packard, SONOS 2000). For each subject, optimalCardiology Research and Practice 3
brachial artery images were obtained between 2 and 10cm
above the antecubital fossa. After baseline measurements
of brachial artery diameter and ﬂow velocity, a small-
width blood pressure cuﬀ (Hokanson SC-10, Seattle, WA,
USA) was inﬂated on the proximal portion of the forearm
to occlusive pressure (200mmHg) for 5 minutes in order
to induce reactive hyperemia. The cuﬀ was then rapidly
deﬂated. Immediately after deﬂation, pulsed Doppler signals
were recorded for 15 seconds. Two-dimensional images of
the brachial artery were taken for 60 to 90 seconds after cuﬀ
deﬂation. The FMD was expressed as the percent change
in diameter relative to the baseline diameter at rest. The
average peak velocity was obtained from the pulsed Doppler
signals recorded at rest and immediately after cuﬀ deﬂation.
The ﬂow volume in the brachial artery was calculated by
multiplying the average peak velocity and the vessel cross-
sectional area ((πD2)/4; D indicates the luminal diameter of
thebrachialartery)derivedfromthebrachialarterydiameter
using the formula: brachial blood ﬂow (ml/min) = average
peak velocity (cm/s)/2 × πD2 × 0.15. Reactive hyperemia
was deﬁned as the relative increase in the brachial blood
ﬂow calculated as the maximal ﬂow measured immediately
after cuﬀ deﬂation divided by the ﬂow obtained at rest
(baseline). Finally, after a 15-minute interval, nitroglycerin-
induced vasodilation (NTG-D) was performed. Baseline
measurements of brachial artery diameter and ﬂow velocity
were again obtained, and 0.3mg of sublingual nitroglycerin
was then administered. Three minutes later, the brachial
artery diameter was recorded. NTG-D was deﬁned as the
percent change relative to the baseline diameter. All images
were recorded on super VHS videotape for later analysis.
All ultrasound study and parameter measurements were
performed by an investigator who was blinded to the other
clinical information. A previous study in our laboratory
showed that the intra- and interobserver variabilities (coef-
ﬁcient of variation) for repeated measures of diameter before
and after reactive hyperemia in the brachial artery were <3%
[12].
2.6.DataAnalysis. WithrespecttotheVESTrecordings:The
beat-to-beat data were taken over 30-second intervals, from
which the end-diastolic volume, the end-systolic volume,
the stroke volume, the left ventricular ejection fraction, the
cardiac output, the left ventricular peak ejection ratio, and
the left ventricular peak ﬁlling ratio were calculated. The
background factor was corrected to obtain the best correla-
tion with measurements taken with the gamma camera. The
VEST system does not permit absolute measurements; end-
diastolic volume data obtained at the beginning of the study
were considered to be 100%, and subsequent measurements
were expressed relative to this initial value. The SVR was
calculatedbydividingthemeanbloodpressurebythecardiac
output obtained using the VEST measurements.
In order to assess the VEST parameters, changes from
the values at 2 minutes after standing on the treadmill
system (rest) to those at the AT point were calculated for
the left ventricular ejection fraction, the left ventricular peak
ejection ratio, and the SVR using the following formulas:
changes in the left ventricular ejection fraction from rest
to AT (%) = (left ventricular ejection fraction at AT − left
ventricular ejection fraction at rest); changes in the left
ventricular peak ejection ratio from rest to AT (%) = ((left
ventricular peak ejection ratio at AT − left ventricular peak
ejection ratio at rest)/left ventricular peak ejection ratio at
rest ×100);changesintheSVRwerealsocalculatedusingthe
same formulas as those for the left ventricular peak ejection
ratio.
2.7. Statistical Analysis. Continuous variables are presented
as the mean value ± standard deviation. Analysis of variance
for repeated one-way ANOVA was applied to the data
obtained at rest and during cardiopulmonary stress testing.
When making multiple comparisons, signiﬁcant probability
values were deﬁned and adjusted using the Bonferroni
method. The relationships between variables were deter-
mined by doing simple linear regression analysis. A P value
of less than 0.05 was considered statistically signiﬁcant.
All analyses were done on a personal computer with the
statistical program Statview, Version 5.0 (SAS institute, Cary,
NC).
3. Results
AllpatientsexercisedbeyondAT(16.3±3.3mL/min/kg)until
exhaustion without any ischemic ST-segment changes on
electrocardiography. Heart rate and systolic blood pressure
signiﬁcantly increased from rest to AT or peak exercise. The
double product and the body weight-corrected VO2 showed
similar changes to the heart rate (Table 1).
The sequential data obtained using the VEST system are
shown in Table 2. The left ventricular ejection fraction and
stroke volume signiﬁcantly increased from rest to AT or
peak exercise. The left ventricular ejection fraction and left
ventricular peak ejection ratio signiﬁcantly increased from
rest to AT or peak exercise (Table 2).
The FMD measurement results showed a signiﬁcant
increase of brachial artery diameter and calculated brachial
artery blood ﬂow (diameter, from 5.1 ± 0.7mm to 5.2 ±
7.3mm, P<. 05; blood ﬂow, from 15 ± 13mL/sec to
65 ± 21mL/sec, P<. 05). From these data, the calculated
FMD was 2.5% ± 2.0%, which was below the normal range
obtained in our laboratory [13]. In contrast, NTG-D was
13.5 ± 4.3, which was within the normal limits obtained in
our laboratory.
There was a signiﬁcant inverse correlation between the
changes in the SVR from rest to AT and the changes in left
ventricular ejection fraction or left ventricular peak ejection
ratio from rest to AT (Figure 1). FMD was signiﬁcantly
correlatedwiththechangeinleftventricularejectionfraction
from rest to AT, and it tended to correlate with the changes
seen in left ventricular peak ejection ratio from rest to AT
(Figure 2). However, these relationships were not observed
for NTG-D.
ACE-inhibitors have a potent eﬀect on endothelial
function (FMD); their use may confound the relationship
between these various parameters [14, 15]. When FMD4 Cardiology Research and Practice
Table 1: The summary of cardiopulmonary stress testing.
Rest AT Peak P-values
Rest versus AT or Peak
HR (bpm) 72 ±13 101 ±12 130 ±14 <. 01
SBP (mmHg) 120 ±16 133 ±23 156 ±22 <. 01
DBP (mmHg) 68 ±10 71 ±97 4 ±10 .29
VO2/W(mL∗min−1 ∗kg−1)4 .5 ±2.11 6 .3 ±3.32 4 .2 ±7.5 <. 01
Data are presented as the mean value ± standard deviation. HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; VO2/ W :o x y g e nu p t a k e
corrected by body weight; AT: anaerobic threshold point; Peak: at peak exercise.
Table 2: The summary of the selected parameters obtained from VEST system.
Rest AT Peak P-values
Rest versus AT or Peak
EF (%) 54 ±12 65 ±16 57 ±10 <. 01
PER (EDV0∗sec−1)3 .1 ±0.93 .6 ±1.04 .3 ±0.9 <. 01
SVR (mmHg∗EDV0−1 ∗min−1)2 .6 ±0.81 .3 ±0.41 .2 ±0.2 <. 01
Data are presented as the mean value ± standard deviation. EF: ejection fraction; PER: peak ejection ratio; SVR: systemic vascular resistance; AT: anaerobic
threshold; Peak: at peak exercise.
values were compared in patients with and without ACE-
inhibitors, the patients with ACE-inhibitors tended to have
better values of FMD than those without ACE-inhibitors
(2.5 ± 1.9% versus 1.8 ± 2.2, P<. 1). Thus, when
patients on ACE-inhibitor treatment were excluded from
the analysis, the FMD signiﬁcantly correlated with both
the left ventricular ejection fraction and the left ventricular
peak ejection ratio change that occurred from rest to AT
(Figure 3). In addition, if the correlation between the FMD
and SVR during exercise was analyzed in this group of
patients, there were a tendency to an inverse correlation
(Figure 4).
4. Discussion
The present study has demonstrated that: (1) peripheral
endothelial function possibly contributes to left ventricular
performance during exercise; (2) SVR during exercise can
determine left ventricular performance in response to aer-
obic exercise; and (3) peripheral endothelial function may
partly contribute to SVR during aerobic exercise in patients
with heart disease.
The correlation coeﬃcient obtained in this study sup-
ports the possible presence of a signiﬁcant relationship
between peripheral endothelial function and left ventric-
ular performance during aerobic exercise when patients
on ACE-inhibitors were excluded. As well, a signiﬁcant
relationship between SVR and left ventricular performance
was conﬁrmed. In addition, peripheral endothelial function
tended to correlate with the SVR obtained during aerobic
exercise. Before reaching the anaerobic threshold, exercise is
considered to be aerobic if no ischemia exists. In this study,
no ischemic ECG changes were observed at the AT points
in any of the patients studied. Thus, all of the patients were
exercising aerobically when the contributions of peripheral
endothelial function and SVR on left ventricular perfor-
mance were observed. However, when the relatively low
correlation coeﬃcient r value and the inﬂuence of ACE-
inhibitors were considered, the deﬁnite role of peripheral
endothelial function on left ventricular performance during
exercise should be conﬁrmed by duplicated larger cohort
study of our observation.
By using a combination of the VEST system and blood
pressure measurements [16], we could calculate dynamic
SVR. The changes in the SVR that occur during exercise
reﬂect peripheral vasomotion during exercise. The VEST
system is useful for evaluating not only serial cardiac
function but also peripheral vasomotion during exercise
in the upright position. By using this device, one can
simultaneously evaluate left ventricular ejection fraction,
cardiac output, stroke volume, left ventricular end diastolic
volume, left ventricular end systolic volume, and the left
ventricular peak ejection ratio [17, 18].
The ﬁndings in this study give a new insight into the
exercise physiology of patients with heart disease. Cardiac
performance is closely associated with dynamic SVR during
exercise obtained using the new VEST system. Cardiopul-
monary stress testing in combination with the VEST system
can be more widely applied in clinical practice to help
manage heart disease. Using this modality, we can evaluate
the eﬃcacy of a new medication or a new therapeutic option,
such as biventricular pacing, in patients with heart failure.
Furthermore, the mechanisms of action of new treatments
can also be elucidated.
Peripheral endothelial function contributes not only to
resting cardiac function but also to the dynamic cardiac
functionchange that occurs during exercise. One couldspec-
ulate that direct and indirect mechanisms are responsible
for this phenomenon. However, the present study’s ﬁndings
cannot help clarify these mechanisms. While in one studyCardiology Research and Practice 5
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Figure 1: The correlation between the percent changes in systemic peripheral vascular resistance and cardiac response to exercise. EF: left
ventricular ejection fraction; SVR: systemic peripheral vascular resistance; AT: anaerobic threshold; PER: peak ejection rate.
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Figure 2: The correlation between ﬂow-mediated vasodilation and cardiac response to exercise. FMD: ﬂow-mediated vasodilation; EF: left
ventricular ejection fraction; PER: peak ejection rate.
nitric oxide aggravated cardiac function in patients with
heart disease [19], other reports have shown that nitric
oxide improved cardiac function in the failing heart [20,
21]. There are three distinct nitric oxide synthases (NOS),
neural (nNOS), inducible (iNOS), and endothelial (eNOS),
that probably behave diﬀerently in the failing heart at rest
and during exercise. Generally, nitric oxide is reported to
modulate β adrenergic responsiveness [22], and nitric oxide
can regulate myocardial oxygen consumption (MVO2) in the
failing heart [23, 24]. Therefore, nitric oxide could possibly
aﬀect cardiac performance even during exercise [25]. With
respect to indirect mechanisms, exercise-induced hyperemia
in either skeletal or cardiac muscle is at least partly nitric
oxide-dependent [26]. A previous report found that nitric6 Cardiology Research and Practice
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Figure 3: The correlation between ﬂow-mediated vasodilation and cardiac response to exercise in the patients not on ACE-inhibitors. FMD:
ﬂow-mediated vasodilation; EF: left ventricular ejection fraction; PER: peak ejection rate.
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Figure 4: The correlation between ﬂow-mediated vasodilation
and changes in systemic peripheral vascular resistance during
exerciseinthepatientsnotonACE-inhibitors.FMD:ﬂow-mediated
vasodilation; SVR: systemic peripheral vascular resistance.
oxide was related to microvascular function in humans [27].
Exercise training and exercise therapy in patients with heart
disease improved both endothelial function and peripheral
vascular circulation [28–32]. Brachial artery endothelial
function may be indirectly associated with cardiac function
during exercise. Since endothelial function could possibly
be related with cardiac function during exercise, medical
therapy,includingprescribingACE-inhibitors,statinsand/or
antioxidant therapy, as well as exercise training, might
improve cardiac function during exercise by improving
endothelial function in patients with heart disease.
In our study, brachial (peripheral) endothelial function
tended to correlate with the systemic vascular response that
occurred during exercise. However, this tendency was only
observed when patients on ACE-inhibitors were excluded
from the analysis, as ACE-inhibitors have potent eﬀects on
endothelial function even after having been discontinued for
24 hours [14, 15]. There are many neurohormonal factors
that play a role in exercise physiology and pathophysiology
[33]. Among them, nitric oxide has been reported to be
involvedin20%–40%oftheentirecontrolofthevasomotion
during exercise. Thus, the moderate correlation obtained in
this study agrees with previously reported ﬁndings.
Study limitations: this study has several limitations.
First, the study population was not homogeneous; thus,
diﬀerent baseline characteristics might have confounded the
main ﬁndings of the present study. This study should be
duplicated with more homogeneous populations. Second,
endothelial function during exercise could not be measured
due to technical problems. If a new technology that measures
endothelial function during exercise could be developed, the
role of endothelial function in systemic vascular resistance
and left ventricular function during exercise would be
further elucidated. Third, since recently statisticians criticize
investigators for utilizing the correlation analysis between
the changes in two measured values [34] and recommend to
use Blomquist’s formula, our results might have less impact
on the relation between peripheral endothelial function
and left ventricular performance during exercise. However,Cardiology Research and Practice 7
the criticizing report is relatively new and, in addition,
commercially available personal computer package of this
statistics does not exist so that we could not analyze our
data by using Blomquist’s formula. Our ﬁndings should
be further conﬁrmed by new analysis in the near future.
Fourth,bytherecentadvanceoftechnology,FMDandNTG-
D now can be measured by on-line system [35] so that
our method of measuring FMD and NTG-D is somewhat
out of date. We did not have duplex measurements to
obtain ﬂow and shear rates, and the time to peak for FMD
could not be determined by our method. In contrast, recent
report [35] especially showed that the time to peak for
FMD exceeded more than 90 seconds. In addition, about
NTG-D, on-line continuous measurement for NTG-D, is
supposed to be important to obtain peak NTG-D value.
These somewhat out-of-date methods likely confound the
interpretation of FMD, NTG-D and the reactive hyperemic
response of brachial artery ﬂow. Our data again should
be duplicated in recent sophisticated equipment. However,
since the huge amount of articles on FMD and NTG-D
have been published by using same measurement method as
ours, our ﬁndings have signiﬁcant message on the relation
between peripheral endothelial function and left ventricular
performanceduringexercise.Lastly,ourVestsystemcanonly
measure relative change of left ventricular dimension so that
absolute value of the left ventricular volume parameters such
as stroke volume that directly inﬂuence exercise tolerance
could not be evaluated. This is another limitation of this
study.
Despite these limitations, we can conclude that periph-
eral endothelial function and vasomotion, including SVR,
might play a signiﬁcant role in determining cardiac perfor-
mance during exercise in patients with heart disease. This
information provides a new insight into the understanding
of the exercise physiology of patients with heart disease.
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